# A Study to Evaluate the Effect of T89(Dantonic®)on Steady-State Pharmacodynamics of Warfarin

> **NCT01475279** · PHASE1 · COMPLETED · sponsor: **Tasly Pharmaceuticals, Inc.** · enrollment: 24 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Warfarin; Dantonic

## Key facts

- **NCT ID:** NCT01475279
- **Lead sponsor:** Tasly Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-07
- **Primary completion:** 2011-11
- **Final completion:** 2012-01
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2012-11-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01475279

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01475279, "A Study to Evaluate the Effect of T89(Dantonic®)on Steady-State Pharmacodynamics of Warfarin". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01475279. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*